Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Want to see ARWR full AI Analyst Report?
ARWR Analyst Ratings
Strong Buy
8 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ARWR Stock 12 Month Forecast
Average Price Target
$89.25
▲(28.40% Upside)
| Highest Price Target$110.00 | Average Price Target$89.25 | Lowest Price Target$46.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bernstein
$35→$46
Hold
-33.82%
Downside
Assigned
05/13/26
H.C. Wainwright
$100
Buy
43.86%
Upside
Reiterated
05/12/26
Piper Sandler
$110
Buy
58.25%
Upside
Reiterated
05/08/26
Chardan Capital
$90
Buy
29.48%
Upside
Reiterated
05/08/26
RBC Capital
$87
Buy
25.16%
Upside
Reiterated
05/07/26
TD Cowen
―
Buy
―
Reiterated
05/05/26
J.P. Morgan
$88
Buy
26.60%
Upside
Initiated
05/01/26
Morgan Stanley
$78→$100
Buy
43.86%
Upside
Upgraded
04/21/26
Bank of America Securities
$81→$93
Buy
33.79%
Upside
Reiterated
04/20/26
Leerink Partners
―
Hold
―
Reiterated
03/26/26
B. Riley Securities
$61→$101
Buy
45.30%
Upside
Reiterated
01/22/26
Goldman Sachs
$50→$85
Hold
22.28%
Upside
Reiterated
01/07/26
Citi
$27.8→$17
Hold
-75.54%
Downside
Reiterated
09/03/25
Barclays
$63→$12
Hold
-82.74%
Downside
Downgraded
07/21/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bernstein
$35→$46
Hold
-33.82%
Downside
Assigned
05/13/26
H.C. Wainwright
$100
Buy
43.86%
Upside
Reiterated
05/12/26
Piper Sandler
$110
Buy
58.25%
Upside
Reiterated
05/08/26
Chardan Capital
$90
Buy
29.48%
Upside
Reiterated
05/08/26
RBC Capital
$87
Buy
25.16%
Upside
Reiterated
05/07/26
TD Cowen
―
Buy
―
Reiterated
05/05/26
J.P. Morgan
$88
Buy
26.60%
Upside
Initiated
05/01/26
Morgan Stanley
$78→$100
Buy
43.86%
Upside
Upgraded
04/21/26
Bank of America Securities
$81→$93
Buy
33.79%
Upside
Reiterated
04/20/26
Leerink Partners
―
Hold
―
Reiterated
03/26/26
B. Riley Securities
$61→$101
Buy
45.30%
Upside
Reiterated
01/22/26
Goldman Sachs
$50→$85
Hold
22.28%
Upside
Reiterated
01/07/26
Citi
$27.8→$17
Hold
-75.54%
Downside
Reiterated
09/03/25
Barclays
$63→$12
Hold
-82.74%
Downside
Downgraded
07/21/25
Best Analysts Covering Arrowhead Pharmaceuticals
3 Months
xxx
Success Rate
18/26 ratings generated profit
Average Return
+28.17%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +28.17% per trade.
1 Year
Success Rate
19/26 ratings generated profit
Average Return
+114.10%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 73.08% of your transactions generating a profit, with an average return of +114.10% per trade.
2 Years
xxx
Success Rate
26/26 ratings generated profit
Average Return
+203.84%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +203.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ARWR Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
4
5
5
5
3
Buy
16
14
8
7
9
Hold
9
7
5
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
26
18
15
14
Each month's total comprises the sum of three months' worth of ratings.
ARWR Financial Forecast
ARWR Stock Forecast FAQ
What is ARWR’s average 12-month price target, according to analysts?
Based on analyst ratings, Arrowhead Pharmaceuticals’s 12-month average price target is 89.25.
What is ARWR’s upside potential, based on the analysts’ average price target?
Arrowhead Pharmaceuticals has 28.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARWR a Buy, Sell or Hold?
Arrowhead Pharmaceuticals has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
What is Arrowhead Pharmaceuticals’s price target?
The average price target for Arrowhead Pharmaceuticals is 89.25. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $110.00 ,the lowest forecast is $46.00. The average price target represents 28.40% Increase from the current price of $69.51.
The highest analyst price target is $110.00 ,the lowest forecast is $46.00. The average price target represents 28.40% Increase from the current price of $69.51.
What do analysts say about Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of ARWR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.